Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Bioregenx (BRGX) Accounts Payables (2021 - 2025)

Bioregenx (BRGX) has 5 years of Accounts Payables data on record, last reported at $459652.0 in Q3 2025.

  • For Q3 2025, Accounts Payables fell 6.71% year-over-year to $459652.0; the TTM value through Sep 2025 reached $459652.0, down 6.71%, while the annual FY2024 figure was $427478.0, 76.87% up from the prior year.
  • Accounts Payables reached $459652.0 in Q3 2025 per BRGX's latest filing, down from $568799.0 in the prior quarter.
  • Across five years, Accounts Payables topped out at $568799.0 in Q2 2025 and bottomed at $11996.0 in Q4 2021.
  • Average Accounts Payables over 5 years is $243864.4, with a median of $241695.0 recorded in 2023.
  • Peak YoY movement for Accounts Payables: soared 1784.61% in 2024, then crashed 80.57% in 2025.
  • A 5-year view of Accounts Payables shows it stood at $11996.0 in 2021, then surged by 64.4% to $19721.0 in 2022, then surged by 1125.57% to $241695.0 in 2023, then surged by 76.87% to $427478.0 in 2024, then rose by 7.53% to $459652.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Accounts Payables were $459652.0 in Q3 2025, $568799.0 in Q2 2025, and $72061.0 in Q1 2025.